2 Information about fulvestrant

Information about fulvestrant

Marketing authorisation

Fulvestrant (Faslodex, AstraZeneca) is indicated for 'the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:

Recommended dose and schedule

The recommended dosage is 500 mg intramuscularly into the buttocks as 2×5‑ml injections (1 in each buttock) on days 1, 15 and 29, and then once monthly (until disease progression).


A pack of 2×5‑ml (50 mg/ml) prefilled syringes costs £522.41 (NHS indicative price, British national formulary online, August 2017). Costs may vary in different settings because of negotiated procurement discounts.

  • National Institute for Health and Care Excellence (NICE)